Завершено
Фаза III
Беларусь
SAR442168 60мг · Genzyme Corporation, a Sanofi affiliated company
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Primary Progressive Multiple Sclerosis (PERSEUS)